![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » HUTCHINSON TECHNOLOGY RECEIVES FDA CLEARANCE FOR INSPECTRA STO2 TISSUE OXYGENATION MONITOR
HUTCHINSON TECHNOLOGY RECEIVES FDA CLEARANCE FOR INSPECTRA STO2 TISSUE OXYGENATION MONITOR
Hutchinson Technology Incorporated announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing its InSpectra StO2 Tissue Oxygenation Monitor. The patented device uses near infrared technology to noninvasively provide an absolute measurement of local tissue oxygen saturation (StO2). The InSpectra StO2 System is the only such device designed for clinical use in the trauma and emergency medicine settings.
Business Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct